1. Home
  2. BHST vs ACOG Comparison

BHST vs ACOG Comparison

Compare BHST & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

HOLD

Current Price

$4.34

Market Cap

97.7M

Sector

N/A

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

N/A

Current Price

$6.91

Market Cap

110.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BHST
ACOG
Founded
2007
2000
Country
Canada
Canada
Employees
87
57
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
97.7M
110.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BHST
ACOG
Price
$4.34
$6.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$10.00
$16.00
AVG Volume (30 Days)
25.6K
76.2K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$146.27
$139.22
Revenue Next Year
N/A
$134.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.10
$4.50
52 Week High
$12.80
$10.88

Technical Indicators

Market Signals
Indicator
BHST
ACOG
Relative Strength Index (RSI) 49.30 61.56
Support Level $4.27 $6.46
Resistance Level $5.02 $7.69
Average True Range (ATR) 0.12 0.54
MACD 0.02 0.04
Stochastic Oscillator 26.34 63.64

Price Performance

Historical Comparison
BHST
ACOG

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: